nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.10.2003 | Original Paper

Colour junctions as predictors of radiosensitivity: X-irradiation combined with gemcitabine in a lung carcinoma cell line

verfasst von: Natasja Castro Kreder, Chris van Bree, Nicolaas A. P. Franken, Jaap Haveman

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 10/2003

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine whether measurement of colour junctions by fluorescent in situ hybridisation (FISH) can predict radiosensitisation of gemcitabine (2'-2'-difluorodeoxycytidine).

Methods

Human lung carcinoma cells (SW-1573) were irradiated with X-rays with or without incubation of 10 nM gemcitabine for 24 h. Cell survival was determined with clonogenic assay. Colour junctions were measured by whole chromosome FISH of chromosomes 2 and 18 and were scored according to the PAINT method.

Results

A clear radiosensitisation by gemcitabine was observed on cell survival. A significant decrease in the number of colour junctions was observed after gemcitabine treatment compared with radiation treatment alone. The correlation between colour junction induction and cell survival was high for both with and without gemcitabine, but the gemcitabine-sensitised curve did not coincide with the non-sensitised curve.

Conclusions

Gemcitabine-induced radiosensitisation is not predicted by induction of colour junctions in cultured SW-1573 cells. This reduces the clinical applicability of this predictive assay for radiotherapy in combination with gemcitabine.

Begg AC, West CMC (2002) Individualisation of therapy. In: Steel GG (ed) Basic clinical radiobiology. Oxford University Press, New York, pp 241–252

Blackstock AW, Lesser GJ, Fletcher-Steede J, Case LD, Tucker RW, Russo SM, White DR, Miller A (2001) Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 51:1281–1289CrossRefPubMed

Castro Kreder N, Van Bree C, Franken NA, Haveman J (2002) Chromosome aberrations detected by FISH and correlation with cell survival after irradiation at various dose-rates and after bromodeoxyuridine radiosensitization. Int J Radiat Biol 78:203–210CrossRefPubMed

Coco-Martin JM, Begg AC (1997) Detection of radiation-induced chromosome aberrations using fluorescence in situ hybridization in drug-induced premature chromosome condensations of tumour cell lines with different radiosensitivities. Int J Radiat Biol 71:265–273CrossRefPubMed

Coco-Martin JM, Smeets MF, Poggensee M, Mooren E, Hofland I, van den Brug M, Ottenheim C, Bartelink H, Begg AC (1994) Use of fluorescence in situ hybridization to measure chromosome aberrations as a predictor of radiosensitivity in human tumour cells. Int J Radiat Biol 66:297–307PubMed

Coco-Martin JM, Ottenheim CP, Bartelink H, Begg AC (1996) Lethality of radiation-induced chromosome aberrations in human tumour cell lines with different radiosensitivities. Int J Radiat Biol 69:337–344CrossRefPubMed

Coco Martin JM, Mooren E, Ottenheim C, Burrill W, Nunez MI, Sprong D, Bartelink H, Begg AC (1999) Potential of radiation-induced chromosome aberrations to predict radiosensitivity in human tumour cells. Int J Radiat Biol 75:1161–1168CrossRefPubMed

Franken NA, Ruurs P, Ludwikow G, van Bree C, Kipp JB, Darroudi F, Barendsen GW (1999) Correlation between cell reproductive death and chromosome aberrations assessed by FISH for low and high doses of radiation and sensitization by iodo-deoxyuridine in human SW-1573 cells. Int J Radiat Biol 75:293–299CrossRefPubMed

Girinsky T, Bernheim A, Lubin R, Tavakoli-Razavi T, Baker F, Janot F, Wibault P, Cosset JM, Duvillard P, Duverger A et al. (1994) In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival. Int J Radiat Oncol Biol Phys 30:789–794PubMed

Grégoire V, Hittelman WN, Rosier JF, Milas L (1999) Chemo-radiotherapy: radiosensitizing nucleoside analogues. Oncol Rep 6:949–957PubMed

Gregor A, Price A, Leest AHD van de, Scalliet P, Wets M, Jungnelius U, Lemmens JP, Groen HJ (1999) Phase I study of gemcitabine and radiotherapy in stage III non-small cell lung cancer. Proc ASCO 18:506a (Abstr)

Haveman J, Rietbroek RC, Geerdink A, Van Rijn J, Bakker PJ (1995) Effect of hyperthermia on the cytotoxicity of 2',2'-difluorodeoxycytidine (gemcitabine) in cultured SW1573 cells. Int J Cancer 62:627–630PubMed

Heinemann V, Hertel LW, Grindey GB, Plunkett W (1998) Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine. Cancer Res 48:4024–4031

Hertel LW, Boder GB, Kroin JS, Rinzel SM, Poore GA, Todd GC, Grindey GB (1990) Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine). Cancer Res 50:4417–4422PubMed

Latz D, Fleckenstein K, Eble M, Blatter J, Wannenmacher M, Weber KJ (1998) Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro. Int J Radiat Oncol Biol Phys 41:875–882CrossRefPubMed

Lawrence TS, Chang EY, Hahn TM, Hertel LW, Shewach DS (1996) Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine. Int J Radiat Oncol Biol Phys 34:867–872CrossRefPubMed

Manegold C, Zatloukal P, Krejcy K, Blatter J (2000) Gemcitabine in non-small cell lung cancer (NSCLC). Invest New Drugs 18:29–42CrossRefPubMed

Natarajan AT, Vyas RC, Darroudi F, Vermeulen S (1992) Frequencies of X-ray-induced chromosome translocations in human peripheral lymphocytes as detected by in situ hybridization using chromosome-specific DNA libraries. Int J Radiat Biol 61:199–203PubMed

Ostruszka LJ, Shewach DS (2000) The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine. Cancer Res 60:6080–6088PubMed

Pinkel D, Straume T, Gray JW (1986) Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83:2934–2938PubMed

Preston RJ (1980) The effect of cytosine arabinoside on the frequency of X-ray-induced chromosome aberrations in normal human leukocytes. Mutat Res 69:71–79CrossRefPubMed

Rockwell S, Grindey GB (1992) Effect of 2',2'-difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro. Oncol Res 4:151–155PubMed

Rosier JF, Beauduin M, Bruniaux M, de Bast M, de Coster B, Octave-Prignot M, Scalliet P, Grégoire V (1999) The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity. Int J Radiat Biol 75:245–251CrossRefPubMed

Russell NS, Arlett CF, Bartelink H, Begg AC (1995) Use of fluorescence in situ hybridization to determine the relationship between chromosome aberrations and cell survival in eight human fibroblast strains. Int J Radiat Biol 68:185–196PubMed

Scalliet P, Goor C, Galdermans D, Meerbeek J Va, Groen HJ, Leest AHD Van de, Westerink H, Jungnelius U, Turrisi A (1998) Gemzar (gemcitabine) with thoracic radiotherapy: a phase II pilot study in chemo-naïve patients with advanced non-small lung cancer (NSCLC). Proc ASCO 17:499a (Abstr)

Shewach DS, Hahn TM, Chang E, Hertel LW, Lawrence TS (1994) Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res 54:3218–3223PubMed

Shewach DS, Lawrence TS (1996) Radiosensitization of human solid tumor cell lines with gemcitabine. Semin Oncol 23:65–71

Tucker JD, Ramsey MJ, Lee DA, Minkler JL (1993) Validation of chromosome painting as a biodosimeter in human peripheral lymphocytes following acute exposure to ionizing radiation in vitro. Int J Radiat Biol 64:27–37PubMed

Tucker JD, Morgan WF, Awa AA, Bauchinger M, Blakey D, Cornforth MN, Littlefield LG, Natarajan AT, Shasserre CA (1995) A proposed system for scoring structural aberrations detected by chromosome painting. Cytogenet Cell Genet 68:211–221PubMed

Van Bree C, Castro Kreder N, Loves WJ, Franken NA, Peters GJ, Haveman J (2002) Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines. Int J Radiat Oncol Biol Phys 54:237–244PubMed

Van Putten JWG, Groen HJM, Smid K, Peters GJ, Kampinga HH (2001) End-joining deficiency and radiosensitization induced by gemcitabine. Cancer Res 61:1585–1591PubMed

Vokes EE, Leopold KA, Herndon JEI, Crawford J, Perry MC, Miller AA, Green MR (1999) A randomized phase II study of gemcitabine or paclitaxel or vinorelbine with cisplatin as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer(NSCLC) (CALGB Study 9431). Proc ASCO 18:459a (Abstr)

West CM, Davidson SE, Roberts SA, Hunter RD (1997) The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer 76:1184–1190PubMed

Weiss C, Grabenbauer GG, Sauer R, Distel L (2003) Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine. Strahlenther Onkol 179:93–98PubMed

Zinner R, Frank F, Komaki R, Delclos M, Jung M, Bonnie G, Jin L, Pisters K, Jhingran A, Waun H (1999) Phase I trial of concurrent gemcitabine (G) plus chest radiotherapy (XRT), followed by consolidation systemic chemotherapy with G plus cisplatin (CDDP), for patients with stage III and medically inoperable stage II non-small cell lung cancer (NSCLC). Proc ASCO 18:466a (Abstr)

Titel: Colour junctions as predictors of radiosensitivity: X-irradiation combined with gemcitabine in a lung carcinoma cell line
verfasst von: Natasja Castro Kreder
Chris van Bree
Nicolaas A. P. Franken
Jaap Haveman
Publikationsdatum: 01.10.2003
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 10/2003
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-003-0479-x

Springer Medizin

Colour junctions as predictors of radiosensitivity: X-irradiation combined with gemcitabine in a lung carcinoma cell line

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2003

Comparison of human lung cancer/SCID mouse tumor xenografts and cell culture growth with patient clinical outcomes

Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells

p16 INK4A Alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas

Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials

Differential enhancement of collagen crosslink excretion in cases of osteosarcoma and chondrosarcoma

Analysis of MYH Tyr165Cys and Gly382Asp variants in childhood leukemias

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie